Urgent.News

What's breaking now, across thousands of outlets.

Culture

Novel Immune Modulator Promising in Acute Respiratory Distress Syndrome

(MedPage Today) -- PHOENIX -- A novel exosome-based immunomodulatory agent appeared promising in speeding recovery from acute respiratory distress syndrome (ARDS), a phase IIb trial showed. The inhaled therapy substantially increased the proportion...

Novel Immune Modulator Promising in Acute Respiratory Distress Syndrome

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Culture

Daddy Musk Is Buying the Love of America's Ungrateful Children

Elon Musk wants to give America's children free SpaceX stock. They can take Daddy's money without having to love him in return.

  • Elon Musk plans to give one SpaceX stock share to every American child.
  • Approximately 72 million American children will receive the shares.
  • The gesture costs around $10.5 billion, a small fraction of Musk's fortune.

More from Tuesday 20 October →